Skip to content

Free cash flow at other companies

Humana logo
HumanaHUM
$1.13B+380%
CVS Health logo
CVS HealthCVS
$3.4B-10.8%
UnitedHealth Group logo
UnitedHealth GroupUNH
$8.15B+78.8%
Astrana Health logo
Astrana HealthASTH
$64.06M+372%
Agilon Health logo
Agilon HealthAGL
$20.63M+158%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$107.04M+750%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%

Valuation

See full
Market cap$1.31B+170%
Enterprise value$1.31B+143%
P/S1.4×+0.8×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Calculated from InnovAge Holdings, Inc.’s reported figures.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s free cash flow?
InnovAge Holdings, Inc. (INNV) reported free cash flow of $14.54M in Q1 2026.
How has InnovAge Holdings, Inc.'s free cash flow changed year-over-year?
InnovAge Holdings, Inc.'s free cash flow decreased by 33.1% year-over-year, from $21.73M to $14.54M.
What is the long-term trend for InnovAge Holdings, Inc.'s free cash flow?
Over 2 years (2022 to 2025), InnovAge Holdings, Inc.'s free cash flow has grown at a 56.0% compound annual growth rate (CAGR), from -$10.94M to $26.6M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.